glp-1 agonist benefits Cardiovascular of glucagon-like peptide-1 receptor agonists In patients with #obesity, incretin-based
Description
cT1, or corrected T1, uses MRI to assess a composite of liver inflammation and fibrosis and may thereby distinguished between NAFLD and NASH [4]
Pi-Sunyer et al
Guruprasad, K., Reddy, B
Treatment with metformin and DPP-4 inhibitors was associated with a reduced risk of fractures overall [129]
National Institute of Diabetes and Digestive and Kidney Diseases
With injectible GLP-1s, local reactions like itchiness or redness may occur at the injection site
